Abstract
Tisagenlecleucel utilisation and outcomes across refractory, first relapse and multiply relapsed B-cell acute lymphoblastic leukemia: a retrospective analysis of real-world patterns
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have